Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT00861705

Study #:
STUDY00147142

Start Date:
May 09, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT00861705

View Complete Trial Details & Eligibility at ClinicalTrials.gov